Oxaliplatin Injection Market
1 Study Coverage
1.1 Oxaliplatin Injection Product Introduction
1.2 Market by Type
1.2.1 Global Oxaliplatin Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Mannitol
1.2.3 Glucose Solution
1.2.4 Lactose Solution
1.2.5 Other
1.3 Market by Application
1.3.1 Global Oxaliplatin Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Colorectal Cancer
1.3.3 Stomach Cancer
1.3.4 Ovarian Cancer
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oxaliplatin Injection Sales Estimates and Forecasts 2017-2028
2.2 Global Oxaliplatin Injection Revenue Estimates and Forecasts 2017-2028
2.3 Global Oxaliplatin Injection Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oxaliplatin Injection Sales by Region
2.4.1 Global Oxaliplatin Injection Sales by Region (2017-2022)
2.4.2 Global Sales Oxaliplatin Injection by Region (2023-2028)
2.5 Global Oxaliplatin Injection Revenue by Region
2.5.1 Global Oxaliplatin Injection Revenue by Region (2017-2022)
2.5.2 Global Oxaliplatin Injection Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oxaliplatin Injection Sales by Manufacturers
3.1.1 Global Top Oxaliplatin Injection Manufacturers by Sales (2017-2022)
3.1.2 Global Oxaliplatin Injection Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oxaliplatin Injection in 2021
3.2 Global Oxaliplatin Injection Revenue by Manufacturers
3.2.1 Global Oxaliplatin Injection Revenue by Manufacturers (2017-2022)
3.2.2 Global Oxaliplatin Injection Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oxaliplatin Injection Revenue in 2021
3.3 Global Oxaliplatin Injection Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oxaliplatin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oxaliplatin Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oxaliplatin Injection Sales by Type
4.1.1 Global Oxaliplatin Injection Historical Sales by Type (2017-2022)
4.1.2 Global Oxaliplatin Injection Forecasted Sales by Type (2023-2028)
4.1.3 Global Oxaliplatin Injection Sales Market Share by Type (2017-2028)
4.2 Global Oxaliplatin Injection Revenue by Type
4.2.1 Global Oxaliplatin Injection Historical Revenue by Type (2017-2022)
4.2.2 Global Oxaliplatin Injection Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oxaliplatin Injection Revenue Market Share by Type (2017-2028)
4.3 Global Oxaliplatin Injection Price by Type
4.3.1 Global Oxaliplatin Injection Price by Type (2017-2022)
4.3.2 Global Oxaliplatin Injection Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oxaliplatin Injection Sales by Application
5.1.1 Global Oxaliplatin Injection Historical Sales by Application (2017-2022)
5.1.2 Global Oxaliplatin Injection Forecasted Sales by Application (2023-2028)
5.1.3 Global Oxaliplatin Injection Sales Market Share by Application (2017-2028)
5.2 Global Oxaliplatin Injection Revenue by Application
5.2.1 Global Oxaliplatin Injection Historical Revenue by Application (2017-2022)
5.2.2 Global Oxaliplatin Injection Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oxaliplatin Injection Revenue Market Share by Application (2017-2028)
5.3 Global Oxaliplatin Injection Price by Application
5.3.1 Global Oxaliplatin Injection Price by Application (2017-2022)
5.3.2 Global Oxaliplatin Injection Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oxaliplatin Injection Market Size by Type
6.1.1 North America Oxaliplatin Injection Sales by Type (2017-2028)
6.1.2 North America Oxaliplatin Injection Revenue by Type (2017-2028)
6.2 North America Oxaliplatin Injection Market Size by Application
6.2.1 North America Oxaliplatin Injection Sales by Application (2017-2028)
6.2.2 North America Oxaliplatin Injection Revenue by Application (2017-2028)
6.3 North America Oxaliplatin Injection Market Size by Country
6.3.1 North America Oxaliplatin Injection Sales by Country (2017-2028)
6.3.2 North America Oxaliplatin Injection Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Oxaliplatin Injection Market Size by Type
7.1.1 Europe Oxaliplatin Injection Sales by Type (2017-2028)
7.1.2 Europe Oxaliplatin Injection Revenue by Type (2017-2028)
7.2 Europe Oxaliplatin Injection Market Size by Application
7.2.1 Europe Oxaliplatin Injection Sales by Application (2017-2028)
7.2.2 Europe Oxaliplatin Injection Revenue by Application (2017-2028)
7.3 Europe Oxaliplatin Injection Market Size by Country
7.3.1 Europe Oxaliplatin Injection Sales by Country (2017-2028)
7.3.2 Europe Oxaliplatin Injection Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oxaliplatin Injection Market Size by Type
8.1.1 Asia Pacific Oxaliplatin Injection Sales by Type (2017-2028)
8.1.2 Asia Pacific Oxaliplatin Injection Revenue by Type (2017-2028)
8.2 Asia Pacific Oxaliplatin Injection Market Size by Application
8.2.1 Asia Pacific Oxaliplatin Injection Sales by Application (2017-2028)
8.2.2 Asia Pacific Oxaliplatin Injection Revenue by Application (2017-2028)
8.3 Asia Pacific Oxaliplatin Injection Market Size by Region
8.3.1 Asia Pacific Oxaliplatin Injection Sales by Region (2017-2028)
8.3.2 Asia Pacific Oxaliplatin Injection Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Oxaliplatin Injection Market Size by Type
9.1.1 Latin America Oxaliplatin Injection Sales by Type (2017-2028)
9.1.2 Latin America Oxaliplatin Injection Revenue by Type (2017-2028)
9.2 Latin America Oxaliplatin Injection Market Size by Application
9.2.1 Latin America Oxaliplatin Injection Sales by Application (2017-2028)
9.2.2 Latin America Oxaliplatin Injection Revenue by Application (2017-2028)
9.3 Latin America Oxaliplatin Injection Market Size by Country
9.3.1 Latin America Oxaliplatin Injection Sales by Country (2017-2028)
9.3.2 Latin America Oxaliplatin Injection Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oxaliplatin Injection Market Size by Type
10.1.1 Middle East and Africa Oxaliplatin Injection Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oxaliplatin Injection Revenue by Type (2017-2028)
10.2 Middle East and Africa Oxaliplatin Injection Market Size by Application
10.2.1 Middle East and Africa Oxaliplatin Injection Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oxaliplatin Injection Revenue by Application (2017-2028)
10.3 Middle East and Africa Oxaliplatin Injection Market Size by Country
10.3.1 Middle East and Africa Oxaliplatin Injection Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oxaliplatin Injection Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi-Aventis
11.1.1 Sanofi-Aventis Corporation Information
11.1.2 Sanofi-Aventis Overview
11.1.3 Sanofi-Aventis Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi-Aventis Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi-Aventis Recent Developments
11.2 Yakult honsha
11.2.1 Yakult honsha Corporation Information
11.2.2 Yakult honsha Overview
11.2.3 Yakult honsha Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Yakult honsha Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Yakult honsha Recent Developments
11.3 Dr Reddy's laboratories
11.3.1 Dr Reddy's laboratories Corporation Information
11.3.2 Dr Reddy's laboratories Overview
11.3.3 Dr Reddy's laboratories Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Dr Reddy's laboratories Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Dr Reddy's laboratories Recent Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Corporation Information
11.4.2 Sun Pharmaceutical Overview
11.4.3 Sun Pharmaceutical Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sun Pharmaceutical Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sun Pharmaceutical Recent Developments
11.5 Teva
11.5.1 Teva Corporation Information
11.5.2 Teva Overview
11.5.3 Teva Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Teva Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Teva Recent Developments
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Corporation Information
11.6.2 Fresenius Kabi Overview
11.6.3 Fresenius Kabi Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Fresenius Kabi Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Fresenius Kabi Recent Developments
11.7 Hospira(Pfizer)
11.7.1 Hospira(Pfizer) Corporation Information
11.7.2 Hospira(Pfizer) Overview
11.7.3 Hospira(Pfizer) Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Hospira(Pfizer) Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hospira(Pfizer) Recent Developments
11.8 Mylan
11.8.1 Mylan Corporation Information
11.8.2 Mylan Overview
11.8.3 Mylan Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Mylan Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mylan Recent Developments
11.9 Jiangsu Hengrui Medicine
11.9.1 Jiangsu Hengrui Medicine Corporation Information
11.9.2 Jiangsu Hengrui Medicine Overview
11.9.3 Jiangsu Hengrui Medicine Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Jiangsu Hengrui Medicine Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Jiangsu Hengrui Medicine Recent Developments
11.10 Nanjing Pharmaceutical Factory
11.10.1 Nanjing Pharmaceutical Factory Corporation Information
11.10.2 Nanjing Pharmaceutical Factory Overview
11.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Nanjing Pharmaceutical Factory Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Nanjing Pharmaceutical Factory Recent Developments
11.11 Jiangsu Aosaikang Pharmaceutical
11.11.1 Jiangsu Aosaikang Pharmaceutical Corporation Information
11.11.2 Jiangsu Aosaikang Pharmaceutical Overview
11.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
11.12 Qilu Pharmaceutical
11.12.1 Qilu Pharmaceutical Corporation Information
11.12.2 Qilu Pharmaceutical Overview
11.12.3 Qilu Pharmaceutical Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Qilu Pharmaceutical Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Qilu Pharmaceutical Recent Developments
11.13 Hisun Pharmaceutical
11.13.1 Hisun Pharmaceutical Corporation Information
11.13.2 Hisun Pharmaceutical Overview
11.13.3 Hisun Pharmaceutical Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Hisun Pharmaceutical Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Hisun Pharmaceutical Recent Developments
11.14 Lunan Pharmaceutical
11.14.1 Lunan Pharmaceutical Corporation Information
11.14.2 Lunan Pharmaceutical Overview
11.14.3 Lunan Pharmaceutical Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Lunan Pharmaceutical Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Lunan Pharmaceutical Recent Developments
11.15 Luoxin
11.15.1 Luoxin Corporation Information
11.15.2 Luoxin Overview
11.15.3 Luoxin Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Luoxin Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Luoxin Recent Developments
11.16 Halfsky Pharmacy
11.16.1 Halfsky Pharmacy Corporation Information
11.16.2 Halfsky Pharmacy Overview
11.16.3 Halfsky Pharmacy Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Halfsky Pharmacy Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Halfsky Pharmacy Recent Developments
11.17 YRPG
11.17.1 YRPG Corporation Information
11.17.2 YRPG Overview
11.17.3 YRPG Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 YRPG Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 YRPG Recent Developments
11.18 Hainan Jinrui Pharmaceutical
11.18.1 Hainan Jinrui Pharmaceutical Corporation Information
11.18.2 Hainan Jinrui Pharmaceutical Overview
11.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Hainan Jinrui Pharmaceutical Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Hainan Jinrui Pharmaceutical Recent Developments
11.19 Jari Pharmaceutical
11.19.1 Jari Pharmaceutical Corporation Information
11.19.2 Jari Pharmaceutical Overview
11.19.3 Jari Pharmaceutical Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Jari Pharmaceutical Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Jari Pharmaceutical Recent Developments
11.20 Chiatai Tianqing
11.20.1 Chiatai Tianqing Corporation Information
11.20.2 Chiatai Tianqing Overview
11.20.3 Chiatai Tianqing Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Chiatai Tianqing Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Chiatai Tianqing Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oxaliplatin Injection Industry Chain Analysis
12.2 Oxaliplatin Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oxaliplatin Injection Production Mode & Process
12.4 Oxaliplatin Injection Sales and Marketing
12.4.1 Oxaliplatin Injection Sales Channels
12.4.2 Oxaliplatin Injection Distributors
12.5 Oxaliplatin Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oxaliplatin Injection Industry Trends
13.2 Oxaliplatin Injection Market Drivers
13.3 Oxaliplatin Injection Market Challenges
13.4 Oxaliplatin Injection Market Restraints
14 Key Findings in The Global Oxaliplatin Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Oxaliplatin Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Mannitol
Table 3. Major Manufacturers of Glucose Solution
Table 4. Major Manufacturers of Lactose Solution
Table 5. Major Manufacturers of Other
Table 6. Global Oxaliplatin Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Oxaliplatin Injection Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Oxaliplatin Injection Sales by Region (2017-2022) & (K Units)
Table 9. Global Oxaliplatin Injection Sales Market Share by Region (2017-2022)
Table 10. Global Oxaliplatin Injection Sales by Region (2023-2028) & (K Units)
Table 11. Global Oxaliplatin Injection Sales Market Share by Region (2023-2028)
Table 12. Global Oxaliplatin Injection Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Oxaliplatin Injection Revenue Market Share by Region (2017-2022)
Table 14. Global Oxaliplatin Injection Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Oxaliplatin Injection Revenue Market Share by Region (2023-2028)
Table 16. Global Oxaliplatin Injection Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Oxaliplatin Injection Sales Share by Manufacturers (2017-2022)
Table 18. Global Oxaliplatin Injection Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Oxaliplatin Injection Revenue Share by Manufacturers (2017-2022)
Table 20. Oxaliplatin Injection Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Oxaliplatin Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Oxaliplatin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxaliplatin Injection as of 2021)
Table 23. Oxaliplatin Injection Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Oxaliplatin Injection Product Offered
Table 25. Date of Manufacturers Enter into Oxaliplatin Injection Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Oxaliplatin Injection Sales by Type (2017-2022) & (K Units)
Table 28. Global Oxaliplatin Injection Sales by Type (2023-2028) & (K Units)
Table 29. Global Oxaliplatin Injection Sales Share by Type (2017-2022)
Table 30. Global Oxaliplatin Injection Sales Share by Type (2023-2028)
Table 31. Global Oxaliplatin Injection Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Oxaliplatin Injection Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Oxaliplatin Injection Revenue Share by Type (2017-2022)
Table 34. Global Oxaliplatin Injection Revenue Share by Type (2023-2028)
Table 35. Oxaliplatin Injection Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Oxaliplatin Injection Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Oxaliplatin Injection Sales by Application (2017-2022) & (K Units)
Table 38. Global Oxaliplatin Injection Sales by Application (2023-2028) & (K Units)
Table 39. Global Oxaliplatin Injection Sales Share by Application (2017-2022)
Table 40. Global Oxaliplatin Injection Sales Share by Application (2023-2028)
Table 41. Global Oxaliplatin Injection Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Oxaliplatin Injection Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Oxaliplatin Injection Revenue Share by Application (2017-2022)
Table 44. Global Oxaliplatin Injection Revenue Share by Application (2023-2028)
Table 45. Oxaliplatin Injection Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Oxaliplatin Injection Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Oxaliplatin Injection Sales by Type (2017-2022) & (K Units)
Table 48. North America Oxaliplatin Injection Sales by Type (2023-2028) & (K Units)
Table 49. North America Oxaliplatin Injection Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Oxaliplatin Injection Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Oxaliplatin Injection Sales by Application (2017-2022) & (K Units)
Table 52. North America Oxaliplatin Injection Sales by Application (2023-2028) & (K Units)
Table 53. North America Oxaliplatin Injection Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Oxaliplatin Injection Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Oxaliplatin Injection Sales by Country (2017-2022) & (K Units)
Table 56. North America Oxaliplatin Injection Sales by Country (2023-2028) & (K Units)
Table 57. North America Oxaliplatin Injection Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Oxaliplatin Injection Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Oxaliplatin Injection Sales by Type (2017-2022) & (K Units)
Table 60. Europe Oxaliplatin Injection Sales by Type (2023-2028) & (K Units)
Table 61. Europe Oxaliplatin Injection Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Oxaliplatin Injection Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Oxaliplatin Injection Sales by Application (2017-2022) & (K Units)
Table 64. Europe Oxaliplatin Injection Sales by Application (2023-2028) & (K Units)
Table 65. Europe Oxaliplatin Injection Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Oxaliplatin Injection Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Oxaliplatin Injection Sales by Country (2017-2022) & (K Units)
Table 68. Europe Oxaliplatin Injection Sales by Country (2023-2028) & (K Units)
Table 69. Europe Oxaliplatin Injection Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Oxaliplatin Injection Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Oxaliplatin Injection Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Oxaliplatin Injection Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Oxaliplatin Injection Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Oxaliplatin Injection Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Oxaliplatin Injection Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Oxaliplatin Injection Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Oxaliplatin Injection Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Oxaliplatin Injection Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Oxaliplatin Injection Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Oxaliplatin Injection Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Oxaliplatin Injection Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Oxaliplatin Injection Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Oxaliplatin Injection Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Oxaliplatin Injection Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Oxaliplatin Injection Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Oxaliplatin Injection Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Oxaliplatin Injection Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Oxaliplatin Injection Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Oxaliplatin Injection Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Oxaliplatin Injection Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Oxaliplatin Injection Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Oxaliplatin Injection Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Oxaliplatin Injection Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Oxaliplatin Injection Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Oxaliplatin Injection Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Oxaliplatin Injection Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Oxaliplatin Injection Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Oxaliplatin Injection Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Oxaliplatin Injection Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Oxaliplatin Injection Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Oxaliplatin Injection Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Oxaliplatin Injection Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Oxaliplatin Injection Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Oxaliplatin Injection Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Oxaliplatin Injection Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Oxaliplatin Injection Revenue by Country (2023-2028) & (US$ Million)
Table 107. Sanofi-Aventis Corporation Information
Table 108. Sanofi-Aventis Description and Major Businesses
Table 109. Sanofi-Aventis Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Sanofi-Aventis Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sanofi-Aventis Recent Developments
Table 112. Yakult honsha Corporation Information
Table 113. Yakult honsha Description and Major Businesses
Table 114. Yakult honsha Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Yakult honsha Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Yakult honsha Recent Developments
Table 117. Dr Reddy's laboratories Corporation Information
Table 118. Dr Reddy's laboratories Description and Major Businesses
Table 119. Dr Reddy's laboratories Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Dr Reddy's laboratories Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Dr Reddy's laboratories Recent Developments
Table 122. Sun Pharmaceutical Corporation Information
Table 123. Sun Pharmaceutical Description and Major Businesses
Table 124. Sun Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Sun Pharmaceutical Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Sun Pharmaceutical Recent Developments
Table 127. Teva Corporation Information
Table 128. Teva Description and Major Businesses
Table 129. Teva Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Teva Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Teva Recent Developments
Table 132. Fresenius Kabi Corporation Information
Table 133. Fresenius Kabi Description and Major Businesses
Table 134. Fresenius Kabi Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Fresenius Kabi Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Fresenius Kabi Recent Developments
Table 137. Hospira(Pfizer) Corporation Information
Table 138. Hospira(Pfizer) Description and Major Businesses
Table 139. Hospira(Pfizer) Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Hospira(Pfizer) Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Hospira(Pfizer) Recent Developments
Table 142. Mylan Corporation Information
Table 143. Mylan Description and Major Businesses
Table 144. Mylan Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Mylan Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Mylan Recent Developments
Table 147. Jiangsu Hengrui Medicine Corporation Information
Table 148. Jiangsu Hengrui Medicine Description and Major Businesses
Table 149. Jiangsu Hengrui Medicine Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. Jiangsu Hengrui Medicine Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Jiangsu Hengrui Medicine Recent Developments
Table 152. Nanjing Pharmaceutical Factory Corporation Information
Table 153. Nanjing Pharmaceutical Factory Description and Major Businesses
Table 154. Nanjing Pharmaceutical Factory Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. Nanjing Pharmaceutical Factory Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Nanjing Pharmaceutical Factory Recent Developments
Table 157. Jiangsu Aosaikang Pharmaceutical Corporation Information
Table 158. Jiangsu Aosaikang Pharmaceutical Description and Major Businesses
Table 159. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 160. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Jiangsu Aosaikang Pharmaceutical Recent Developments
Table 162. Qilu Pharmaceutical Corporation Information
Table 163. Qilu Pharmaceutical Description and Major Businesses
Table 164. Qilu Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 165. Qilu Pharmaceutical Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Qilu Pharmaceutical Recent Developments
Table 167. Hisun Pharmaceutical Corporation Information
Table 168. Hisun Pharmaceutical Description and Major Businesses
Table 169. Hisun Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 170. Hisun Pharmaceutical Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Hisun Pharmaceutical Recent Developments
Table 172. Lunan Pharmaceutical Corporation Information
Table 173. Lunan Pharmaceutical Description and Major Businesses
Table 174. Lunan Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 175. Lunan Pharmaceutical Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Lunan Pharmaceutical Recent Developments
Table 177. Luoxin Corporation Information
Table 178. Luoxin Description and Major Businesses
Table 179. Luoxin Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 180. Luoxin Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Luoxin Recent Developments
Table 182. Halfsky Pharmacy Corporation Information
Table 183. Halfsky Pharmacy Description and Major Businesses
Table 184. Halfsky Pharmacy Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 185. Halfsky Pharmacy Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Halfsky Pharmacy Recent Developments
Table 187. YRPG Corporation Information
Table 188. YRPG Description and Major Businesses
Table 189. YRPG Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 190. YRPG Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. YRPG Recent Developments
Table 192. Hainan Jinrui Pharmaceutical Corporation Information
Table 193. Hainan Jinrui Pharmaceutical Description and Major Businesses
Table 194. Hainan Jinrui Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 195. Hainan Jinrui Pharmaceutical Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 196. Hainan Jinrui Pharmaceutical Recent Developments
Table 197. Jari Pharmaceutical Corporation Information
Table 198. Jari Pharmaceutical Description and Major Businesses
Table 199. Jari Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 200. Jari Pharmaceutical Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 201. Jari Pharmaceutical Recent Developments
Table 202. Chiatai Tianqing Corporation Information
Table 203. Chiatai Tianqing Description and Major Businesses
Table 204. Chiatai Tianqing Oxaliplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 205. Chiatai Tianqing Oxaliplatin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 206. Chiatai Tianqing Recent Developments
Table 207. Key Raw Materials Lists
Table 208. Raw Materials Key Suppliers Lists
Table 209. Oxaliplatin Injection Distributors List
Table 210. Oxaliplatin Injection Customers List
Table 211. Oxaliplatin Injection Market Trends
Table 212. Oxaliplatin Injection Market Drivers
Table 213. Oxaliplatin Injection Market Challenges
Table 214. Oxaliplatin Injection Market Restraints
Table 215. Research Programs/Design for This Report
Table 216. Key Data Information from Secondary Sources
Table 217. Key Data Information from Primary Sources
List of Figures
Figure 1. Oxaliplatin Injection Product Picture
Figure 3. Global Oxaliplatin Injection Market Share by Type in 2021 & 2028
Figure 3. Mannitol Product Picture
Figure 4. Glucose Solution Product Picture
Figure 5. Lactose Solution Product Picture
Figure 6. Other Product Picture
Figure 7. Global Oxaliplatin Injection Market Share by Application in 2021 & 2028
Figure 8. Colorectal Cancer
Figure 9. Stomach Cancer
Figure 10. Ovarian Cancer
Figure 11. Other
Figure 12. Oxaliplatin Injection Report Years Considered
Figure 13. Global Oxaliplatin Injection Sales 2017-2028 (K Units)
Figure 14. Global Oxaliplatin Injection Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Oxaliplatin Injection Revenue 2017-2028 (US$ Million)
Figure 16. Global Oxaliplatin Injection Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Oxaliplatin Injection Sales Market Share by Region (2017-2022)
Figure 18. Global Oxaliplatin Injection Sales Market Share by Region (2023-2028)
Figure 19. North America Oxaliplatin Injection Sales YoY (2017-2028) & (K Units)
Figure 20. North America Oxaliplatin Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Oxaliplatin Injection Sales YoY (2017-2028) & (K Units)
Figure 22. Europe Oxaliplatin Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Oxaliplatin Injection Sales YoY (2017-2028) & (K Units)
Figure 24. Asia-Pacific Oxaliplatin Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Oxaliplatin Injection Sales YoY (2017-2028) & (K Units)
Figure 26. Latin America Oxaliplatin Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Oxaliplatin Injection Sales YoY (2017-2028) & (K Units)
Figure 28. Middle East & Africa Oxaliplatin Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Oxaliplatin Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Oxaliplatin Injection in the World: Market Share by Oxaliplatin Injection Revenue in 2021
Figure 31. Global Oxaliplatin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Oxaliplatin Injection Sales Market Share by Type (2017-2028)
Figure 33. Global Oxaliplatin Injection Revenue Market Share by Type (2017-2028)
Figure 34. Global Oxaliplatin Injection Sales Market Share by Application (2017-2028)
Figure 35. Global Oxaliplatin Injection Revenue Market Share by Application (2017-2028)
Figure 36. North America Oxaliplatin Injection Sales Market Share by Type (2017-2028)
Figure 37. North America Oxaliplatin Injection Revenue Market Share by Type (2017-2028)
Figure 38. North America Oxaliplatin Injection Sales Market Share by Application (2017-2028)
Figure 39. North America Oxaliplatin Injection Revenue Market Share by Application (2017-2028)
Figure 40. North America Oxaliplatin Injection Sales Share by Country (2017-2028)
Figure 41. North America Oxaliplatin Injection Revenue Share by Country (2017-2028)
Figure 42. United States Oxaliplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Oxaliplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Oxaliplatin Injection Sales Market Share by Type (2017-2028)
Figure 45. Europe Oxaliplatin Injection Revenue Market Share by Type (2017-2028)
Figure 46. Europe Oxaliplatin Injection Sales Market Share by Application (2017-2028)
Figure 47. Europe Oxaliplatin Injection Revenue Market Share by Application (2017-2028)
Figure 48. Europe Oxaliplatin Injection Sales Share by Country (2017-2028)
Figure 49. Europe Oxaliplatin Injection Revenue Share by Country (2017-2028)
Figure 50. Germany Oxaliplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 51. France Oxaliplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Oxaliplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Oxaliplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Oxaliplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Oxaliplatin Injection Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Oxaliplatin Injection Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Oxaliplatin Injection Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Oxaliplatin Injection Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Oxaliplatin Injection Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Oxaliplatin Injection Revenue Share by Region (2017-2028)
Figure 61. China Oxaliplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Oxaliplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Oxaliplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 64. India Oxaliplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Oxaliplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 66. China Taiwan Oxaliplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Oxaliplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Oxaliplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Oxaliplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Oxaliplatin Injection Sales Market Share by Type (2017-2028)
Figure 71. Latin America Oxaliplatin Injection Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Oxaliplatin Injection Sales Market Share by Application (2017-2028)
Figure 73. Latin America Oxaliplatin Injection Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Oxaliplatin Injection Sales Share by Country (2017-2028)
Figure 75. Latin America Oxaliplatin Injection Revenue Share by Country (2017-2028)
Figure 76. Mexico Oxaliplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Oxaliplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Oxaliplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Oxaliplatin Injection Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Oxaliplatin Injection Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Oxaliplatin Injection Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Oxaliplatin Injection Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Oxaliplatin Injection Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Oxaliplatin Injection Revenue Share by Country (2017-2028)
Figure 85. Turkey Oxaliplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Oxaliplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 87. UAE Oxaliplatin Injection Revenue (2017-2028) & (US$ Million)
Figure 88. Oxaliplatin Injection Value Chain
Figure 89. Oxaliplatin Injection Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
Industry Market Size
